Elevated expression of ZEB2 is associated with degree of malignancy, rapid cell proliferation, and poor patient survival in different tumors [8], [9], [14], suggesting that ZEB2 expression may have significant value as a biomarker in glioma patients. Here, ZEB2 is linked to central nervous system cancer.